Spruce Biosciences, Inc. (SPRB)
39.65
-1.82
(-4.39%)
USD |
NASDAQ |
Oct 16, 16:00
40.00
+0.35
(+0.88%)
After-Hours: 20:00
Spruce Biosciences Market Cap : 109.15M for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 109.15M |
| October 15, 2026 | 114.16M |
| October 14, 2026 | 107.30M |
| October 13, 2026 | 111.08M |
| October 12, 2026 | 118.01M |
| October 09, 2026 | 121.26M |
| October 08, 2026 | 125.36M |
| October 07, 2026 | 122.22M |
| October 06, 2026 | 117.78M |
| October 05, 2026 | 125.03M |
| October 02, 2026 | 125.83M |
| October 01, 2026 | 123.24M |
| September 30, 2026 | 133.73M |
| September 29, 2026 | 130.12M |
| September 28, 2026 | 130.79M |
| September 25, 2026 | 134.12M |
| September 24, 2026 | 134.94M |
| September 23, 2026 | 136.03M |
| September 22, 2026 | 137.61M |
| September 21, 2026 | 147.83M |
| September 18, 2026 | 146.04M |
| September 17, 2026 | 148.27M |
| September 16, 2026 | 149.09M |
| September 15, 2026 | 151.86M |
| September 14, 2026 | 156.50M |
| Date | Value |
|---|---|
| September 11, 2026 | 147.83M |
| September 10, 2026 | 149.61M |
| September 09, 2026 | 153.44M |
| September 08, 2026 | 162.66M |
| September 04, 2026 | 159.47M |
| September 03, 2026 | 158.86M |
| September 02, 2026 | 164.26M |
| September 01, 2026 | 153.06M |
| August 31, 2026 | 162.33M |
| August 28, 2026 | 167.32M |
| August 27, 2026 | 174.25M |
| August 26, 2026 | 169.24M |
| August 25, 2026 | 174.53M |
| August 24, 2026 | 161.45M |
| August 21, 2026 | 141.99M |
| August 20, 2026 | 143.10M |
| August 19, 2026 | 145.79M |
| August 18, 2026 | 145.47M |
| August 17, 2026 | 145.68M |
| August 14, 2026 | 144.91M |
| August 13, 2026 | 137.01M |
| August 12, 2026 | 129.57M |
| August 11, 2026 | 127.76M |
| August 10, 2026 | 127.18M |
| August 07, 2026 | 129.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.291B |
| Alnylam Pharmaceuticals, Inc. | 31.00B |
| Anika Therapeutics, Inc. | 267.39M |
| Savara, Inc. | 914.03M |
| Vericel Corp. | 2.053B |
Market Cap Related Metrics
| Price to Book Value | 1.304 |
| Price | 39.65 |
| Earnings Yield | -103.1% |